Welcome to our dedicated page for Illumina SEC filings (Ticker: ILMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Illumina SEC filings document the company’s genomics technology business, financial results, governance and capital actions. Form 8-K reports cover quarterly and annual operating results, preliminary financial updates, share repurchase authorization, management and board changes, and Regulation FD disclosures.
The filing record also includes definitive proxy materials for annual meeting matters, director elections, compensation and shareholder voting. Material-event filings document completed acquisition activity, including the purchase of SomaLogic and Sengenics aptamer-based and functional proteomics assets, along with exhibits, common-stock repurchase disclosures and other capital-structure records.
ILLUMINA, INC. executive Scott D. Ericksen, the VP and Chief Accounting Officer, reported a Form 4 transaction involving a tax-related share disposition. On February 15, 2026, he disposed of 694 shares of Common Stock in a tax-withholding transaction at $116.51 per share, leaving him with 13,229 directly owned shares.
ILLUMINA, INC. Chief of Global Operations Kevin Carl Pegels reported a Form 4 transaction involving company common stock. On this date, he disposed of 1,164 shares at a price of $116.51 per share to satisfy tax obligations by delivering shares rather than paying cash. After this tax-withholding disposition, he directly holds 22,721 shares of Illumina common stock.
Illumina, Inc. Chief Legal Officer Scott M. Davies reported a tax-related share disposition. On February 15, 2026, he transferred 1,037 shares of common stock to cover tax liabilities at a price of $116.51 per share, and held 17,670 shares directly afterward.
ILLUMINA, INC. Chief Executive Officer Jacob Thaysen reported a Form 4 transaction involving a tax-related share disposition. On this transaction, 6,544 shares of common stock were withheld at a price of $116.51 per share to cover tax liabilities, and he held 83,339 shares directly afterward.
ILLUMINA, INC. senior vice president Jakob Wedel Christensen reported a tax-withholding disposition of 578 shares of common stock at $116.51 per share on February 15, 2026. This transaction satisfied tax obligations by delivering shares rather than representing an open-market sale.
Following this Form 4 transaction, he directly owned 10,374 shares of Illumina common stock, reflecting his remaining equity stake after the tax-related share delivery.
Illumina, Inc. SVP and Chief People Officer Patricia Leckman reported two stock transactions. She sold 2,370 shares of common stock in an open-market sale at $116.18 per share on February 18, 2026, and disposed of 1,304 shares on February 15, 2026 to cover taxes. After these transactions, she directly owned 16,321 shares.
Morgan Stanley Smith Barney LLC filed a Form 144 notice listing the proposed sale of Common stock related to ILMN. The filing lists 2,370 shares with an aggregate value of $275,346.60 and a date of 02/18/2026. The excerpt also shows two restricted stock items dated 11/05/2024 (637 shares) and 01/05/2025 (1,733 shares).
Barnard Steven reported multiple insider transaction types in a Form 4 filing for ILMN. The filing lists transactions totaling 6,368 shares at a weighted average price of $114.44 per share. Following the reported transactions, holdings were 34,287 shares.
Illumina, Inc. Chief Executive Officer Jacob Thaysen reported equity award activity involving company stock. On February 12, 2026, he acquired 13,264 shares of common stock through the exercise and conversion of performance share units at an exercise price of $0 per share, reflecting the company achieving at least 74% of specified performance goals.
On the same date, 5,470 shares of common stock were disposed of at $114.44 per share to satisfy tax withholding obligations related to this award. After these transactions, Thaysen directly beneficially owned 89,883 shares of Illumina common stock.
Illumina, Inc. executive Kevin Carl Pegels, Chief of Global Operations, reported equity award activity on February 12, 2026. He exercised 2,283 performance share units at an exercise price of $0, receiving 2,283 shares of common stock and bringing his direct holdings to 24,759 shares.
In a related tax-withholding transaction, 874 common shares were disposed of at $114.44 per share to satisfy tax obligations, leaving him with 23,885 directly owned shares. The 2,283 shares reflect a performance award tied to at least 74% achievement of performance criteria from a March 1, 2023 performance share grant.